Evidence map›Paper›PMID 40496123›Full record

ArticleFrontiers in neurology2025

Color memory as a diagnostic test for mild cognitive impairment and early stage of Alzheimer's disease.

Vaiva Sutnikiene, Egle Audronyte, Gyte Pakulaite-Kazliene, Gintaras Kaubrys

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vaiva SutnikieneClinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Egle AudronyteClinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Gyte Pakulaite-KazlieneClinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Gintaras KaubrysClinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Color vision and memory are potential markers of Alzheimer's disease (AD); however, information regarding their changes in early AD remains limited. Objective: The aim of this study was to evaluate color recognition memory in mild cognitive impairment (MCI), early Alzheimer's disease (AD), and older adults with normal cognition, as well as to assess its diagnostic properties. Methods: We included 27 participants with mild dementia (MD), 25 with MCI, and 25 older adults with normal cognition who served as the control group (CG). Participants completed the Mini-Mental Status Examination (MMSE), the Clinical Dementia Rating (CDR), and the Alzheimer's disease Assessment Scale-Cognitive Subscale (ADAS-Cog 13) for cognitive assessment; delayed word recall (after 30 min), the Ishihara test, and a color recognition memory test were also administered. The color recognition memory test was performed using a basic 12-color kit displayed on a computer screen. Color recognition was evaluated after 5 and 30 min using four initial stimuli and four new colors from the 12-color kit. Participants were required to recognize which of the eight randomly presented colors they had previously seen. Results: Significant differences were observed in the total error scores for color recognition memory among the three groups. Medians (interquartile range) for CG, MCI, and MD groups were 2 (2), 4 (2), and 5 (3) respectively. A Kruskal-Wallis test returned a significant Conclusion: Color recognition memory test results differed significantly between participants with normal cognition and those with MCI and early AD. Therefore, it may help in the early diagnosis of AD as a simple, non-invasive diagnostic marker.

Indexed as

Alzheimer’s diseasecolor memorycolor recognition memorycolor visionmild cognitive impairment

Identifiers

PMID40496123
PMCPMC12148855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.